UNSPSC 51384511: Ketoprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 90Y4QC304K, chemically known as propionic acid, 2-(3-benzoylphenyl)- but generally known as ketoprofen, which bears US NIH Compound Identifier 3825. European Medicines Agency schedules Ketoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08374MIG.

UNSPSC 51384511 Ketoprofen is a Commodity code that addresses pharmaceutical procurement; however, the single recent state and local opportunity tagged under this code does not align with its nominal scope. Seminole County, Florida's IFB60459723LAS solicitation, posted June 30, 2026 with a due date of July 26, 2023, seeks procurement of naloxone and safe drug deactivation systems rather than ketoprofen. The mismatch suggests either a coding error in the source data or a broader pharmaceutical-procurement classification that encompasses emergency-response medications beyond the narrow ketoprofen scope. State and local buyers do not show recent documented activity requesting ketoprofen specifically under this code.

No representative recent ketoprofen procurement opportunities are present in the available data. The single opportunity on record—Seminole County's naloxone and drug deactivation systems IFB—falls outside the code's intended commodity boundary and does not reflect active demand for ketoprofen among state, county, municipal, or special-purpose district buyers. Practitioners evaluating this code should verify current UNSPSC alignment and monitor for future pharmaceutical solicitations that may clarify whether state and local procurement in this class focuses on naloxone, ketoprofen, or a broader emergency-response medication category.